Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging evidence for adapting radiotherapy to immunotherapy
Lorenzo Galluzzi, Molykutty J. Aryankalayil, C. Norman Coleman, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 543-557
Closed Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 76
Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 59
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 49
Cancer cell metabolism and antitumour immunity
Mara De Martino, Jeffrey C. Rathmell, Lorenzo Galluzzi, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 654-669
Open Access | Times Cited: 44
Oxygen‐driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy
Pei Pei, Yuhong Wang, Wenhao Shen, et al.
Aggregate (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 27
An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy
Yuhua Cao, Shuaishuai Ding, Yunping Hu, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4189-4204
Closed Access | Times Cited: 27
Immunoadjuvant-Functionalized Metal-Organic Frameworks：Synthesis and Applications in Tumor Immune Modulation
Chen Zhao, Weihua Song, Jianing Wang, et al.
Chemical Communications (2024)
Closed Access | Times Cited: 26
Immunogenicity of ferroptosis in cancer: a matter of context?
Elena Catanzaro, Robin Demuynck, Faye Naessens, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 407-416
Closed Access | Times Cited: 15
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1514-1532.e15
Open Access | Times Cited: 14
Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer
Che-Wei Chang, Szu‐Ting Yang, Hung‐Hsien Liu, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 5, pp. 651-664
Open Access | Times Cited: 14
Rational design of a nonclassical liposomal nanoscale drug delivery system for innovative cancer therapy
Chunjie Wang, Xiaoqi Sun, Liangzhu Feng, et al.
BMEMat (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 13
ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response
Ali Bakr, G Corte, Olivera Veselinov, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 10, pp. 5698-5719
Open Access | Times Cited: 12
Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization
Rui Qiao, Zhongwen Yuan, Meijin Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 29
Open Access | Times Cited: 12
Biomaterials with cancer cell-specific cytotoxicity: challenges and perspectives
Zhaoyou Chu, Wanni Wang, Zheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 17, pp. 8847-8877
Closed Access | Times Cited: 12
NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Zhiheng Zhang, Bojiao Song, Haowei Wei, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101040-101040
Closed Access | Times Cited: 11
Unrestricted molecular motions enable mild photothermy for recurrence-resistant FLASH antitumor radiotherapy
Hanchen Shen, Hongbin Wang, Jianlan Mo, et al.
Bioactive Materials (2024) Vol. 37, pp. 299-312
Open Access | Times Cited: 10
Dismantlable Coronated Nanoparticles for Coupling the Induction and Perception of Immunogenic Cell Death
Huan Liang, Chunchen Xu, Daoxia Guo, et al.
Advanced Materials (2024) Vol. 36, Iss. 27
Closed Access | Times Cited: 9
Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders
Pui Lam Yip, Rui You, Ming‐Yuan Chen, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 383-383
Open Access | Times Cited: 8
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Neoadjuvant chemoradiation with or without PD-1 blockade in locally advanced rectal cancer: a randomized phase 2 trial
Yingchi Yang, Kangfeng Pang, Guole Lin, et al.
Nature Medicine (2025) Vol. 31, Iss. 2, pp. 449-456
Closed Access | Times Cited: 1
Metal‐Protein Hybrid Materials: Unlocking New Frontiers in Biomedical Applications
Yong Pan, Han Zhao, Wenyong Huang, et al.
Advanced Healthcare Materials (2025)
Open Access | Times Cited: 1
Molecular mechanisms of m6A modifications regulating tumor radioresistance
Ruolin Shen, Zhenyang Jiang, Huanhuan Wang, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Molecular determinants of immunogenic cell death elicited by radiation therapy
Claudia Galassi, Vanessa Klapp, Takahiro Yamazaki, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 20-32
Open Access | Times Cited: 19
Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy
Qiaohong Geng, Peifu Jiao
Molecules (2024) Vol. 29, Iss. 2, pp. 454-454
Open Access | Times Cited: 7
Killing two birds with one stone: Abscopal effect mechanism and its application prospect in radiotherapy
Boyi Yu, Yuting Gao, Jiaxin Li, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104325-104325
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top